<http://webisa.webdatacommons.org/prov/414309075>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/169753223> .
<http://webisa.webdatacommons.org/169753223>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/169753223>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<bio-medicine.org> .
<http://webisa.webdatacommons.org/169753223>	<http://www.w3.org/ns/prov#value>	"executive transition or performance or other issues or risks associated" .
<http://webisa.webdatacommons.org/prov/355455206>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/169753223> .
<http://webisa.webdatacommons.org/prov/506370892>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/169753223> .
<http://webisa.webdatacommons.org/prov/476333231>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/169753223> .